Kushwah, V.; Arora, S.; Tamás Katona, M.; Modhave, D.; Fröhlich, E.; Paudel, A.
On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet. Pharmaceutics 2021, 13, 283.
https://doi.org/10.3390/pharmaceutics13020283
AMA Style
Kushwah V, Arora S, Tamás Katona M, Modhave D, Fröhlich E, Paudel A.
On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet. Pharmaceutics. 2021; 13(2):283.
https://doi.org/10.3390/pharmaceutics13020283
Chicago/Turabian Style
Kushwah, Varun, Sumit Arora, Miklós Tamás Katona, Dattatray Modhave, Eleonore Fröhlich, and Amrit Paudel.
2021. "On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet" Pharmaceutics 13, no. 2: 283.
https://doi.org/10.3390/pharmaceutics13020283
APA Style
Kushwah, V., Arora, S., Tamás Katona, M., Modhave, D., Fröhlich, E., & Paudel, A.
(2021). On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet. Pharmaceutics, 13(2), 283.
https://doi.org/10.3390/pharmaceutics13020283